Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
12.09 USD | +0.25% | -4.50% | -15.51% |
May. 14 | Transcript : OptimizeRx Corporation, Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | OptimizeRx Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.51% | 220M | |
+27.72% | 426B | |
+30.24% | 276B | |
+2.74% | 135B | |
+7.17% | 92.01B | |
+25.57% | 89.16B | |
+66.56% | 58.86B | |
+10.11% | 45.03B | |
+19.19% | 34.77B | |
-11.61% | 31.93B |
- Stock Market
- Equities
- OPRX Stock
- News OptimizeRx Corporation
- B. Riley Cuts OptimizeRx's Price Target to $18 From $28 on Muted H2 Revenue Expectation, Keeps Buy Rating